Comprehensive Evaluation of Multiple Approaches Targeting ABCB1 to Resensitize Docetaxel-Resistant Prostate Cancer Cell Lines

Docetaxel (DTX) is a mainstay in the treatment of metastatic prostate cancer. Failure of DTX therapy is often associated with multidrug resistance caused by overexpression of efflux membrane transporters of the ABC family such as the glycoprotein ABCB1. This study investigated multiple approaches ta...

Descripción completa

Detalles Bibliográficos
Autores principales: Linke, Dinah, Donix, Lukas, Peitzsch, Claudia, Erb, Holger H. H., Dubrovska, Anna, Pfeifer, Manuel, Thomas, Christian, Fuessel, Susanne, Erdmann, Kati
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820728/
https://www.ncbi.nlm.nih.gov/pubmed/36614114
http://dx.doi.org/10.3390/ijms24010666

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820728/
https://www.ncbi.nlm.nih.gov/pubmed/36614114
http://dx.doi.org/10.3390/ijms24010666

Ejemplares similares